cold saline solution bolus via a central venous catheter, a thermistor-tipped arterial catheter (usually femoral) is connected to a specific monitor (PiCCOplus; Pulsion Medical Systems; Munich, Germany), which records the downstream temperature changes, ie, a transpulmonary thermodilution curve. The mathematical analysis of the curve allows the computation of cardiac output, heart blood volume (global end-diastolic volume), and an estimation of extravascular lung water. [1][2][3][4] Recently, the mere observation of the transpulmonary thermodilution curve has been shown to be useful to detect and monitor right-to-left intracardiac shunting. 5 Indeed, in case of right-to-left intracardiac shunt, one part of the cold indicator passes through the atrial septum and rapidly reaches the arterial thermistor. As a result, the thermodilution curve appears prematurely and becomes biphasic with two humps ("camel" curve). 5 I would like to report such a camel thermodilution curve that was not related to a right-to-left intracardiac shunt. This curve was recorded in a patient with septic shock instrumented with a right femoral thermistor-tipped arterial catheter and a right femoral venous catheter. Both catheters were of the same length (20 cm). When the cold saline solution was injected through the femoral venous line, the transpulmonary thermodilution curve was highly suggestive of right-to-left intracardiac shunting (Fig 1) . However, the patient was not hypoxemic and contrast echocardiography as well as color Doppler imaging did not reveal any intracardiac shunt. Because both arterial and venous femoral catheters were on the same side and of the same length, it was hypothesized that the high concentration of cold indicator at the site of injection (the tip of the venous catheter) may induce significant temperature changes in the femoral artery, ie, at the level of the arterial catheter tip equipped with a thermistor (cross-talk phenomenon). To confirm this hypothesis, central venous injections were also performed through an internal jugular line. In this case, the shape of the transpulmonary thermodilution curve was normal (Fig 1) .
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Following several reports of severe liver injury, the American Thoracic Society and the Centers for Infection Control and Prevention recently recommended to discontinue the use of rifampin plus pyrazinamide (RZ) as treatment for latent tuberculosis (LTB). 1 Considering the limited choice of drugs proven effective for this purpose, in our opinion this advice, though judicious and precautionary, is a cause of major concerns. In the United States, the implementation of mandatory screening and treatment for LTB in immigrants from high-prevalence countries actually encounters relevant difficulties because of the variable isoniazid (INH) resistance patterns among different countries, and of possible severe hepatotoxicity associated with antituberculosis drugs. High primary INH resistance rates have been registered among immigrants from Vietnam, South Korea, Haiti, the Philippines, and China. In fact, a decision analysis model predicted that RZ would be the most effective and the least expensive option for immigrants from Vietnam, Haiti, and the Philippines. 2 This issue may be even more cogent in Europe, given the massive migratory flows from low-income countries and considering that, unlike the United States, HIV-positive legal immigrants, who are at higher risk for active tuberculosis, are not expelled. The European framework for tuberculosis control and elimination, including the recommendation of using INH for LTB treatment in specific groups, has been recently published. 3 Nevertheless, in different European countries the origin of the immigrants' population may vary, and consequently the level of INH resistance too. For instance, in a multicenter study 4 in Italy, in 2000 primary INH resistance in immigrants was reported to be 9.4%. In a survey of patients referred to the General Hospital of Verona from January 2000 to June 2003, among 231 isolates of Mycobacterium tuberculosis, 28 of 41 of strains (68.3%) resistant to at least one antituberculosis drug were from immigrants (23.9% of cases in this category of patients). Overall resistance to INH was detected in 23 strains (9.9%); 60.8% of these were isolated in immigrants from the African continent (mainly Senegal, Ghana, Ivory Coast, and Nigeria) who were infected by INH-resistant strains in 22.2% of cases. These data highlight that in the area of Verona, the INH resistance rate among immigrants is much higher compared to the national level. Therefore, the use of INH as LTB treatment could be inadequate in nearly one of four African immigrants. We believe that it is essential to evaluate the origin of immigrants in a specific area while preparing national and local guidelines for LTB treatment because of the possibility of different resistance patterns. Considering the high level of INH resistance in some endemic areas, regimens including rifampin should be recommended. Nevertheless, following the recent withdrawal of the RZ regimen in the United States, new options for LTB treatment are urgently needed. In the meantime, based on a cost-effectiveness evaluation, we would suggest that in young immigrants from high tuberculosis prevalence countries with known high INH resistance, especially if at increased risk, such as HIV-positive subjects, RZ could be still considered in absence of any hepatopathy. 
Angelo Cazzadori, MD, FCCP

Care of Flexible Bronchoscopes
To the Editor
We experienced an unusual complication with two flexible bronchoscopes within a week. The following letter is meant to alert others, and is intended for both education and cost savings.
The flexible A-rubber sheath on the distal portion of the bronchoscope "ballooned," and in one bronchoscope ruptured, during the sterilization process. As the repairs cost roughly $1,000 (Canadian dollars) per bronchoscope and this had never happened in our institution before, we set out to uncover the problem.
The following two simultaneous conditions were believed to be responsible: a failing check valve in the sterilizer; and the fact that the bronchoscopes had been placed into the sterilizer with a slight positive internal pressure following leak testing. A failing check valve can add as much as 6 to 7.6 lb per square inch of vacuum to the exterior surface of the bronchoscope. Any positive pressure that is left in the bronchoscope from the leak test procedure could add as much as 3.5 lb per square inch of pressure. 1 Together, the additional pressure could cause dilation and/or rupture of the rubber sheath.
To prevent a repeat, we have emphasized the need for maintenance on any sterilizing equipment at least twice per year. As part of our own ongoing quality assurance efforts, a check step to the leak test procedure has been added to ensure that no positive pressure remains prior to sterilization. By briefly installing a venting cap onto the bronchoscope following leak testing, all remaining positive pressure is removed. To facilitate this, an ethylene oxide cap was chained to the leak tester.
Although not a common problem, the cost of repair mandates an extra effort. We think that this simple step, which requires minimal time, no extra training, and the negligible cost of a venting cap, will prevent future damage. We encourage readers to consider their own bronchoscope-venting procedures.
